Keywords: Liver, Quantitative ImagingCorrected T1 (cT1) is potential to be a novel imaging biomarker, which was based on T1 mapping corrected for iron content. The results of this study showed the high correlation between cT1 value and NAFLD activity, without correlation with fibrosis. There was high accuracy of cT1 to identify normal liver and liver with NAFLD, as well as mild and severe NAFLD. The severer inflammation, the higher heterogeneity of cT1 mapping. Thus, cT1 may be used for evaluating liver inflammation of patient with NAFLD, especially for those without severe fibrosis, and may evaluate heterogeneity further.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords